Interim Clinical Commissioning Policy: Tocilizumab for hospitalised patients with COVID-19 pneumonia (adults), NHS England (updated 6th October 2021)

The proposal is: tocilizumab is recommended to be available as a treatment option through routine commissioning for adult patients (aged 18 years and older) hospitalised with COVID-19 in accordance with the criteria set out in this document.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Actemra | COVID-19 | Health | Pneumonia